DRG Market Assessment Reports

Report January 10, 2023

Acute Myeloid Leukemia – Epidemiology – Emerging Markets

Clarivate Epidemiology’s coverage of acute myeloid leukemia (AML) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and…

north_east

Report January 10, 2023

Acute Myeloid Leukemia – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key Acute myeloid leukemia patient populations, covering 171 countries…

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Middle East & Africa

Clarivate Epidemiology’s coverage of non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL) comprises epidemiological estimates of key patient populations in 45 countries worldwide…

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Asia-Pacific

north_east

Report September 1, 2022

NK/T-Cell Lymphoma – Epidemiology – Extrapolated Worldwide Coverage

Clarivate’s extended worldwide coverage is the first and only evidence-based data set of epidemiological forecasts for key NK/T-cell patient populations covering 171 countries and more than 99%…

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Europe

north_east

Report September 1, 2022

NK/T-Cell Lymphoma – Epidemiology – Asia Pacific

Clarivate Epidemiology’s coverage of NK/T-cell lymphoma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report both the incidence and prevalence of…

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Americas

north_east

Report September 1, 2022

NK/T-Cell Lymphoma – Epidemiology – Middle East and Africa

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Emerging Markets

north_east

Report September 1, 2022

NK/T-Cell Lymphoma – Epidemiology – Europe

north_east

Report September 1, 2022

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Mature Markets

north_east

Product logins

DRG Market Assessment reports

Acute Myeloid Leukemia – Epidemiology – Emerging Markets

Acute Myeloid Leukemia – Epidemiology – Extrapolated Worldwide Coverage

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Middle East & Africa

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Asia-Pacific

NK/T-Cell Lymphoma – Epidemiology – Extrapolated Worldwide Coverage

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Europe

NK/T-Cell Lymphoma – Epidemiology – Asia Pacific

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Americas

NK/T-Cell Lymphoma – Epidemiology – Middle East and Africa

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Emerging Markets

NK/T-Cell Lymphoma – Epidemiology – Europe

Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia – Epidemiology – Mature Markets

Follow us

Contact us